RXRX logo

RXRX Selling, General & Administrative Expenses

Annual SGA

$178.18 M
+$67.36 M+60.78%

December 31, 2024


Summary


Performance

RXRX SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRXRXexpensesmetrics:

Quarterly SGA

$77.19 M
+$39.43 M+104.43%

December 31, 2024


Summary


Performance

RXRX Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRXRXexpensesmetrics:

TTM SGA

-$4.90 B
-$463.66 M-10.45%

December 31, 2024


Summary


Performance

RXRX TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRXRXexpensesmetrics:

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

RXRX Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+60.8%+104.4%-3826.9%
3 y3 years+208.9%+104.4%-3826.9%
5 y5 years+840.2%+104.4%-3826.9%

RXRX Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+208.9%at high+302.0%-286.6%at low
5 y5-yearat high+840.2%at high+1396.1%-2193.6%at low
alltimeall timeat high+840.2%at high+1396.1%-2193.6%at low

Recursion Pharmaceuticals Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Dec 2024
$178.18 M(+60.8%)
$77.19 M(+104.4%)
$178.18 M(+35.5%)
Sep 2024
-
$37.76 M(+18.6%)
$131.46 M(+7.0%)
Jun 2024
-
$31.83 M(+1.4%)
$122.90 M(+3.0%)
Mar 2024
-
$31.41 M(+3.1%)
$119.36 M(+7.7%)
Dec 2023
$110.82 M(+35.8%)
$30.46 M(+4.3%)
$110.82 M(+10.6%)
Sep 2023
-
$29.20 M(+3.2%)
$100.20 M(+10.7%)
Jun 2023
-
$28.29 M(+23.7%)
$90.49 M(+8.5%)
Mar 2023
-
$22.87 M(+15.3%)
$83.40 M(+2.2%)
Dec 2022
$81.60 M
$19.84 M(+1.8%)
$81.60 M(+0.8%)
Sep 2022
-
$19.49 M(-8.1%)
$80.96 M(+4.9%)
Jun 2022
-
$21.20 M(+0.6%)
$77.16 M(+10.5%)
DateAnnualQuarterlyTTM
Mar 2022
-
$21.07 M(+9.8%)
$69.82 M(+21.0%)
Dec 2021
$57.68 M(+128.4%)
$19.20 M(+22.4%)
$57.68 M(+25.2%)
Sep 2021
-
$15.69 M(+13.3%)
$46.05 M(+23.4%)
Jun 2021
-
$13.85 M(+55.0%)
$37.33 M(+30.4%)
Mar 2021
-
$8.94 M(+18.0%)
$28.63 M(+13.4%)
Dec 2020
$25.26 M(+33.3%)
-
-
Dec 2020
-
$7.57 M(+8.8%)
$25.26 M(+42.8%)
Sep 2020
-
$6.96 M(+35.0%)
$17.68 M(+65.0%)
Jun 2020
-
$5.16 M(-7.2%)
$10.72 M(+92.8%)
Mar 2020
-
$5.56 M
$5.56 M
Dec 2019
$18.95 M
-
-

FAQ

  • What is Recursion Pharmaceuticals annual SGA?
  • What is the all time high annual SGA for Recursion Pharmaceuticals?
  • What is Recursion Pharmaceuticals annual SGA year-on-year change?
  • What is Recursion Pharmaceuticals quarterly SGA?
  • What is the all time high quarterly SGA for Recursion Pharmaceuticals?
  • What is Recursion Pharmaceuticals quarterly SGA year-on-year change?
  • What is Recursion Pharmaceuticals TTM SGA?
  • What is the all time high TTM SGA for Recursion Pharmaceuticals?
  • What is Recursion Pharmaceuticals TTM SGA year-on-year change?

What is Recursion Pharmaceuticals annual SGA?

The current annual SGA of RXRX is $178.18 M

What is the all time high annual SGA for Recursion Pharmaceuticals?

Recursion Pharmaceuticals all-time high annual SGA is $178.18 M

What is Recursion Pharmaceuticals annual SGA year-on-year change?

Over the past year, RXRX annual SGA has changed by +$67.36 M (+60.78%)

What is Recursion Pharmaceuticals quarterly SGA?

The current quarterly SGA of RXRX is $77.19 M

What is the all time high quarterly SGA for Recursion Pharmaceuticals?

Recursion Pharmaceuticals all-time high quarterly SGA is $77.19 M

What is Recursion Pharmaceuticals quarterly SGA year-on-year change?

Over the past year, RXRX quarterly SGA has changed by +$39.43 M (+104.43%)

What is Recursion Pharmaceuticals TTM SGA?

The current TTM SGA of RXRX is -$4.90 B

What is the all time high TTM SGA for Recursion Pharmaceuticals?

Recursion Pharmaceuticals all-time high TTM SGA is -$213.60 M

What is Recursion Pharmaceuticals TTM SGA year-on-year change?

Over the past year, RXRX TTM SGA has changed by -$5.03 B (-3826.87%)